These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20964806)

  • 1. Bond-based 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation.
    Casañola-Martin GM; Marrero-Ponce Y; Khan MT; Khan SB; Torrens F; Pérez-Jiménez F; Rescigno A; Abad C
    Chem Biol Drug Des; 2010 Dec; 76(6):538-45. PubMed ID: 20964806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Sultan S; Torrens F; Rotondo R
    Bioorg Med Chem; 2007 Feb; 15(3):1483-503. PubMed ID: 17110117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
    Marrero-Ponce Y; Khan MT; Casañola Martín GM; Ather A; Sultankhodzhaev MN; Torrens F; Rotondo R
    ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
    Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atom- and bond-based 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors.
    Casañola-Martín GM; Marrero-Ponce Y; Tareq Hassan Khan M; Torrens F; Pérez-Giménez F; Rescigno A
    J Biomol Screen; 2008 Dec; 13(10):1014-24. PubMed ID: 19015291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
    Marrero-Ponce Y; Khan MT; Casañola-Martín GM; Ather A; Sultankhodzhaev MN; García-Domenech R; Torrens F; Rotondo R
    J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tyrosinase inhibitors selected by atomic linear indices-based classification models.
    Casañola-Martín GM; Khan MT; Marrero-Ponce Y; Ather A; Sultankhodzhaev MN; Torrens F
    Bioorg Med Chem Lett; 2006 Jan; 16(2):324-30. PubMed ID: 16275084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
    Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
    Marrero-Ponce Y; Siverio-Mota D; Gálvez-Llompart M; Recio MC; Giner RM; García-Domènech R; Torrens F; Arán VJ; Cordero-Maldonado ML; Esguera CV; de Witte PA; Crawford AD
    Eur J Med Chem; 2011 Dec; 46(12):5736-53. PubMed ID: 22000935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models.
    Rescigno A; Casañola-Martin GM; Sanjust E; Zucca P; Marrero-Ponce Y
    Drug Test Anal; 2011 Mar; 3(3):176-81. PubMed ID: 21125547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New halogenated phenylcoumarins as tyrosinase inhibitors.
    Matos MJ; Santana L; Uriarte E; Delogu G; Corda M; Fadda MB; Era B; Fais A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3342-5. PubMed ID: 21514152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
    Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
    Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
    Castillo-Garit JA; Vega MC; Rolon M; Marrero-Ponce Y; Kouznetsov VV; Torres DF; Gómez-Barrio A; Bello AA; Montero A; Torrens F; Pérez-Giménez F
    Eur J Pharm Sci; 2010 Jan; 39(1-3):30-6. PubMed ID: 19854271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K; Roy PP
    Chem Biol Drug Des; 2008 Nov; 72(5):370-82. PubMed ID: 19012573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
    Xue CB; Zhang L; Luo WC; Xie XY; Jiang L; Xiao T
    Bioorg Med Chem; 2007 Mar; 15(5):2006-15. PubMed ID: 17258462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 2',4',6'-trihydroxychalcones as a new class of tyrosinase inhibitors.
    Jun N; Hong G; Jun K
    Bioorg Med Chem; 2007 Mar; 15(6):2396-402. PubMed ID: 17267225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4D-fingerprints, universal QSAR and QSPR descriptors.
    Senese CL; Duca J; Pan D; Hopfinger AJ; Tseng YJ
    J Chem Inf Comput Sci; 2004; 44(5):1526-39. PubMed ID: 15446810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.